Literature DB >> 3950114

Erythema nodosum leprosum: nature and extent of the cutaneous microvascular alterations.

G F Murphy, N P Sanchez, T C Flynn, J L Sanchez, M C Mihm, N A Soter.   

Abstract

Skin biopsy specimens from four patients with erythema nodosum leprosum, when examined as Epon-embedded, 1-micron sections, exhibited a necrotizing vasculitis involving capillaries, venules, and small-to-medium arteries and veins. In the superficial dermis, affected venules and capillaries showed endothelial cell enlargement and focal necrosis associated with perivascular infiltrates of lymphocytes. In the deep dermis and subcutaneous tissue, affected venules, arterioles, and arteries exhibited endothelial cell necrosis and matted fibrin in the vessel walls associated with perivascular infiltrates of neutrophils. Throughout the dermis, mononuclear phagocytes with vacuoles containing numerous fragmented organisms were observed. By electron microscopy, electron-dense material resembling immune complexes was observed in the walls of these vessels. These observations support the concept that erythema nodosum leprosum is an immune complex-mediated necrotizing vasculitis involving capillaries, arterioles, arteries, venules, and veins.

Entities:  

Mesh:

Year:  1986        PMID: 3950114     DOI: 10.1016/s0190-9622(86)70008-x

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  8 in total

1.  A role for interleukin-5 in promoting increased immunoglobulin M at the site of disease in leprosy.

Authors:  Maria T Ochoa; Rosane Teles; Blake E Haas; Danny Zaghi; Huiying Li; Euzenir N Sarno; Thomas H Rea; Robert L Modlin; Delphine J Lee
Journal:  Immunology       Date:  2010-11       Impact factor: 7.397

Review 2.  [Skin manifestations of different forms of vasculitis].

Authors:  C Sunderkötter
Journal:  Z Rheumatol       Date:  2013-06       Impact factor: 1.372

3.  High expression of myeloid-related proteins 8 and 14 characterizes an inflammatorily active but ineffective response of macrophages during leprosy.

Authors:  Cord H Sunderkötter; Jane Tomimori-Yamashita; Verena Nix; Solange M Maeda; Anca Sindrilaru; Mario Mariano; Clemens Sorg; Johannes Roth
Journal:  Immunology       Date:  2004-04       Impact factor: 7.397

4.  Integrated pathways for neutrophil recruitment and inflammation in leprosy.

Authors:  Delphine J Lee; Huiying Li; Maria T Ochoa; Motoyuki Tanaka; Ryan J Carbone; Robert Damoiseaux; Anne Burdick; Euzenir N Sarno; Thomas H Rea; Robert L Modlin
Journal:  J Infect Dis       Date:  2010-02-15       Impact factor: 5.226

5.  Expression of CD64 on Circulating Neutrophils Favoring Systemic Inflammatory Status in Erythema Nodosum Leprosum.

Authors:  Veronica Schmitz; Rhana Berto da Silva Prata; Mayara Garcia de Mattos Barbosa; Mayara Abud Mendes; Sheila Santos Brandão; Thaís Porto Amadeu; Luciana Silva Rodrigues; Helen Ferreira; Fabrício da Mota Ramalho Costa; Jessica Brandão Dos Santos; Fabiana Dos Santos Pacheco; Alice de Miranda Machado; José Augusto da Costa Nery; Mariana de Andrea Hacker; Anna Maria Sales; Roberta Olmo Pinheiro; Euzenir Nunes Sarno
Journal:  PLoS Negl Trop Dis       Date:  2016-08-24

Review 6.  A Systematic Review of Immunological Studies of Erythema Nodosum Leprosum.

Authors:  Anastasia Polycarpou; Stephen L Walker; Diana N J Lockwood
Journal:  Front Immunol       Date:  2017-03-13       Impact factor: 7.561

Review 7.  Neutrophils in Leprosy.

Authors:  Veronica Schmitz; Isabella Forasteiro Tavares; Patricia Pignataro; Alice de Miranda Machado; Fabiana Dos Santos Pacheco; Jéssica Brandão Dos Santos; Camila Oliveira da Silva; Euzenir Nunes Sarno
Journal:  Front Immunol       Date:  2019-03-19       Impact factor: 7.561

Review 8.  Innate Immune Responses in Leprosy.

Authors:  Roberta Olmo Pinheiro; Veronica Schmitz; Bruno Jorge de Andrade Silva; André Alves Dias; Beatriz Junqueira de Souza; Mayara Garcia de Mattos Barbosa; Danuza de Almeida Esquenazi; Maria Cristina Vidal Pessolani; Euzenir Nunes Sarno
Journal:  Front Immunol       Date:  2018-03-28       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.